T2T-YAO: a Telomere-to-telomere Assembled Diploid Reference Genome for Han Chinese

He, Y.; Chu, Y.; Guo, S.; Hu, J.; Li, R.; Zheng, Y.; Ma, X.; Du, Z.; Zhao, L.; Yu, W.; Xue, J.; Bian, W.; Yang, F.; Chen, X.; Zhang, P.; Wu, R.; Ma, Y.; Shao, C.; Chen, J.; Wang, J.; Li, J.; Wu, J.; Hu, X.; Long, Q.; Jiang, M.; Ye, H.; Song, S.; Li, G.; Wei, Y.; Xu, Y.; Chen, Y.; Wang, K.; Bao, J.; Xi, W.; Wang, F.; Ni, W.; Zhang, M.; Yu, Y.; Li, S.; Kang, Y.; Gao, Z.

doi:10.1101/2023.07.17.549286

bioRxiv · 10.1101/2023.07.17.549286

T2T-YAO: a Telomere-to-telomere Assembled Diploid Reference Genome for Han Chinese

He, Y.·Chu, Y.·Guo, S.·Hu, J.·Li, R.·Zheng, Y.·Ma, X.·Du, Z.·Zhao, L.·Yu, W.·Xue, J.·Bian, W.·Yang, F.·Chen, X.·Zhang, P.·Wu, R.·Ma, Y.·Shao, C.·Chen, J.·Wang, J.·Li, J.·Wu, J.·Hu, X.·Long, Q.·Jiang, M.·Ye, H.·Song, S.·Li, G.·Wei, Y.·Xu, Y.·Chen, Y.·Wang, K.·Bao, J.·Xi, W.·Wang, F.·Ni, W.·Zhang, M.·Yu, Y.·Li, S.·Kang, Y.·Gao, Z.

View original source ↗Export metadata ↓

Abstract

Since its initial release in 2001, the human reference genome has been continuously improved in both continuity and accuracy, and the recently-released telomere-to-telomere version--T2T-CHM13--reaches its top quality after 20 years of effort. However, T2T-CHM13 does not represent an authentic diploid human genome, but rather one derived from a simplified, nearly homozygous genome of a hydatidiform mole cell line. To address this limitation and provide an alternative pertinent to the Chinese population, the largest ethnic group in the world, we have assembled a complete diploid human genome of a male Han Chinese, T2T-YAO, which includes telomere-to-telomere assemblies for all the 22+X+M and 22+Y chromosomes in his two haploids inherited separately from his parents. Both haplotypes contain no artificial sequences or model nucleotides and possess a high quality comparable to CHM13, with fewer than one error per [~]14 Mb. Derived from the individual who lives in the aboriginal region of Han Chinese, T2T-YAO shows clear ancestry and potential genetic continuity from the ancient ancestors of the Han population. Each haplotype of T2T-YAO possesses [~]340 Mb exclusive sequences and [~]3100 unique genes as compared to CHM13, and their genome sequences show greater genetic distance to CHM13 than to each other in terms of nucleotide polymorphism and structural variations. The construction of T2T-YAO would serve as a high-quality diploid reference that enables precise delineation of genomic variations in a haplotype-sensitive manner, which could advance our understandings in human evolution, hereditability of diseases and phenotypes, especially within the context of the unique variations of the Chinese population.

Source connections

Published article ↗

Explore related subjects

genetics Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

He, Y., Chu, Y., Guo, S., Hu, J., Li, R., Zheng, Y., Ma, X., Du, Z., Zhao, L., Yu, W., Xue, J., Bian, W., Yang, F., Chen, X., Zhang, P., Wu, R., Ma, Y., Shao, C., Chen, J., Wang, J., Li, J., Wu, J., Hu, X., Long, Q., Jiang, M., Ye, H., Song, S., Li, G., Wei, Y., Xu, Y., Chen, Y., Wang, K., Bao, J., Xi, W., Wang, F., Ni, W., Zhang, M., Yu, Y., Li, S., Kang, Y., Gao, Z.. 2023-07-19. T2T-YAO: a Telomere-to-telomere Assembled Diploid Reference Genome for Han Chinese. https://doi.org/10.1101/2023.07.17.549286

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

bioRxiv2026

Mechanism-selective deep mutational scanning distinguishes ERCC2 disease phenotypes

Pathogenic ERCC2 variants cause xeroderma pigmentosum (XP), trichothiodystrophy (TTD) or both, yet variant effect scores are usually interpreted only as measures of pathogenicity rather than of which disease mechanism is disrupted. XPD, the ERCC2-encoded TFIIH subunit, functions in both nucleotide excision repair and transcription. Using yeast complementation deep mutational scanning, we measured the effects of nearly all XPD amino acid substitutions. The assay was mechanism-selective: it preferentially reported transcription-associated function, with pronounced intolerance at the p44 interface, whereas many substitutions affecting DNA binding and helicase activity retained near-wild-type fitness. Accordingly, TTD variants had much lower fitness than XP variants. Computational predictors discriminated pathogenic from benign variants similarly across phenotypes, but the DMS distinguished XP from TTD variants better than all 73 predictors tested. Phenotype-specific ACMG/AMP calibration provided evidence in both directions for TTD but mainly pathogenic evidence for XP. Thus, the selectivity of functional assays, often viewed as a limitation, can reveal disease mechanisms and support phenotype-aware variant interpretation.

genetics↗

bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗